1 Abstract
A valuable metric in understanding local infectious disease dynamics is the local time-varying reproduction number, i.e. the expected number of secondary local cases caused by each infected individual. Accurate estimation of this quantity requires distinguishing cases arising from local transmission from those imported from elsewhere. Realistically, we can expect identification of cases as local or imported to be imperfect. We study the propagation of such errors in estimation of the local time-varying reproduction number. In addition, we propose a Bayesian framework for estimation of the true local time-varying reproduction number when identification errors exist. And we illustrate the practical performance of our estimator through simulation studies and with outbreaks of COVID-19 in Hong Kong and Victoria, Australia.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported in part by Army Research Office award W911NF1810237. This work was also supported by National Institutes of Health, R01 GM122878 and R35 GM141821. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This work only used public data and is exempted from IRB/oversight approval.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
No primary data are used in this paper. Secondary data sources are taken from Adam, Dillon C., et al. “Clustering and superspreading potential of SARS-CoV-2 infections in Hong Kong.” Nature Medicine 26.11 (2020): 1714-1719. and Seemann, Torsten, et al. “Tracking the COVID-19 pandemic in Australia using genomics.” Nature communications 11.1 (2020): 1-9. These data and the code necessary to reproduce the results in this paper are available at https://github.com/KolaczykResearch/EstimLocalRt.